Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6,914 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Rapid PD-L1 detection in tumors with PET using a highly specific peptide.
Chatterjee S, Lesniak WG, Miller MS, Lisok A, Sikorska E, Wharram B, Kumar D, Gabrielson M, Pomper MG, Gabelli SB, Nimmagadda S. Chatterjee S, et al. Among authors: kumar d. Biochem Biophys Res Commun. 2017 Jan 29;483(1):258-263. doi: 10.1016/j.bbrc.2016.12.156. Epub 2016 Dec 24. Biochem Biophys Res Commun. 2017. PMID: 28025143 Free PMC article.
Corrigendum to "Rapid PD-L1 detection in tumors with PET using a highly specific peptide" [Biochemical and Biophysical Research Communications 483/1 (2017) 258-263].
Chatterjee S, Lesniak WG, Miller MS, Lisok A, Sikorska E, Wharram B, Kumar D, Gabrielson M, Pomper MG, Gabelli SB, Nimmagadda S. Chatterjee S, et al. Among authors: kumar d. Biochem Biophys Res Commun. 2017 Sep 30;491(4):1125. doi: 10.1016/j.bbrc.2017.08.001. Epub 2017 Aug 8. Biochem Biophys Res Commun. 2017. PMID: 28801167 Free PMC article. No abstract available.
Peptide-Based 68Ga-PET Radiotracer for Imaging PD-L1 Expression in Cancer.
De Silva RA, Kumar D, Lisok A, Chatterjee S, Wharram B, Venkateswara Rao K, Mease R, Dannals RF, Pomper MG, Nimmagadda S. De Silva RA, et al. Among authors: kumar d. Mol Pharm. 2018 Sep 4;15(9):3946-3952. doi: 10.1021/acs.molpharmaceut.8b00399. Epub 2018 Aug 10. Mol Pharm. 2018. PMID: 30037229 Free PMC article.
Peptide-based PET quantifies target engagement of PD-L1 therapeutics.
Kumar D, Lisok A, Dahmane E, McCoy M, Shelake S, Chatterjee S, Allaj V, Sysa-Shah P, Wharram B, Lesniak WG, Tully E, Gabrielson E, Jaffee EM, Poirier JT, Rudin CM, Gobburu JV, Pomper MG, Nimmagadda S. Kumar D, et al. J Clin Invest. 2019 Feb 1;129(2):616-630. doi: 10.1172/JCI122216. Epub 2019 Jan 7. J Clin Invest. 2019. PMID: 30457978 Free PMC article.
Development of [18F]FPy-WL12 as a PD-L1 Specific PET Imaging Peptide.
Lesniak WG, Mease RC, Chatterjee S, Kumar D, Lisok A, Wharram B, Kalagadda VR, Emens LA, Pomper MG, Nimmagadda S. Lesniak WG, et al. Among authors: kumar d. Mol Imaging. 2019 Jan-Dec;18:1536012119852189. doi: 10.1177/1536012119852189. Mol Imaging. 2019. PMID: 31187691 Free PMC article.
Pharmacodynamic measures within tumors expose differential activity of PD(L)-1 antibody therapeutics.
Kumar D, Mishra A, Lisok A, Kureshi R, Shelake S, Plyku D, Sen R, Doucet M, De Silva RA, Mease RC, Forde PM, Jaffee EM, Desai P, Ganguly S, Gabrielson E, Vaidya D, Spangler JB, Nimmagadda S. Kumar D, et al. Proc Natl Acad Sci U S A. 2021 Sep 14;118(37):e2107982118. doi: 10.1073/pnas.2107982118. Proc Natl Acad Sci U S A. 2021. PMID: 34508005 Free PMC article.
Gallium-68-labeled Peptide PET Quantifies Tumor Exposure of PD-L1 Therapeutics.
Mishra A, Kumar D, Gupta K, Lofland G, Sharma AK, Banka DS, Hobbs RF, Dannals RF, Rowe SP, Gabrielson E, Nimmagadda S. Mishra A, et al. Among authors: kumar d. Clin Cancer Res. 2023 Feb 1;29(3):581-591. doi: 10.1158/1078-0432.CCR-22-1931. Clin Cancer Res. 2023. PMID: 36449662 Free PMC article.
6,914 results